MedTrace Logo

Mortality Outcome of Controlled Hypertension

NCT07187596 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2547

Last updated 2026-04-13

No results posted yet for this study

Summary

This pooled analysis investigates death outcomes in patients with pharmacologically treated and blood pressure-controlled hypertension. Despite documented BP control, some patients still suffer fatal cardiovascular, cerebrovascular, renal, or unexplained syndromes. This study aims to synthesize available evidence across study types to identify treatment pitfalls, contributing syndromes, and non-BP factors associated with these fatal outcomes.

February 14th, 2026. Total search hits: 9,297 articles from your hypertension-mortality PubMed strategy Working dataset: 2,547 unique records. Screened so far: 50 (2.0%).

Mostly excluded because:

Not the right treatment strategy. No mortality outcome. Less often: wrong population.

Conditions

Sponsors & Collaborators

  • DejthidaNathaphong

    lead OTHER

Principal Investigators

  • Nathaphong Dejthida, MD · DejthidaNathaphong

Eligibility

Min Age
1 Minute
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-18
Primary Completion
2026-12-18
Completion
2027-12-14

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07187596 on ClinicalTrials.gov